Prestige Consumer Healthcare Inc
PBH62.855USD
+0.435+0.70%
收盘 12/26, 16:00（美东）报价延迟15分钟
3.02B总市值
15.48市盈率 TTM
关于 Prestige Consumer Healthcare Inc 公司
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Prestige Consumer Healthcare Inc简介
公司代码PBH
公司名称Prestige Consumer Healthcare Inc
上市日期Feb 10, 2005
CEOLombardi (Ronald M)
员工数量600
证券类型Ordinary Share
年结日Feb 10
公司地址660 White Plains Rd.
城市TARRYTOWN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编10591
电话19145246800
网址https://www.prestigebrands.com/
公司代码PBH
上市日期Feb 10, 2005
CEOLombardi (Ronald M)
Prestige Consumer Healthcare Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-5.73%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-0.81%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-30.95%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+17.11%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+22.68%
Mr. James C. D'arecca
Mr. James C. D'arecca
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-5.73%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-0.81%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.19%
The Vanguard Group, Inc.
11.40%
Ariel Investments, LLC
7.48%
Dimensional Fund Advisors, L.P.
5.39%
Kayne Anderson Rudnick Investment Management, LLC
4.60%
其他
56.93%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.19%
The Vanguard Group, Inc.
11.40%
Ariel Investments, LLC
7.48%
Dimensional Fund Advisors, L.P.
5.39%
Kayne Anderson Rudnick Investment Management, LLC
4.60%
其他
56.93%
股东类型
持股股东
占比
Investment Advisor
70.09%
Investment Advisor/Hedge Fund
29.81%
Research Firm
3.29%
Hedge Fund
2.49%
Pension Fund
1.40%
Individual Investor
1.31%
Sovereign Wealth Fund
1.15%
Family Office
0.62%
Bank and Trust
0.55%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
2023Q2
589
51.93M
104.86%
-4.95M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.03M
14.28%
-239.29K
-3.29%
Jun 30, 2025
The Vanguard Group, Inc.
5.62M
11.42%
-2.89K
-0.05%
Jun 30, 2025
Ariel Investments, LLC
2.20M
4.47%
-316.61K
-12.57%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.47M
5.02%
-244.43K
-9.00%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.75M
3.55%
+168.12K
+10.64%
Jun 30, 2025
State Street Investment Management (US)
2.00M
4.06%
+1.65K
+0.08%
Jun 30, 2025
Nomura Investment Management Business Trust
1.97M
4%
-285.27K
-12.66%
Jun 30, 2025
Allspring Global Investments, LLC
1.52M
3.09%
-94.00K
-5.82%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.41M
2.87%
+9.46K
+0.67%
Jun 30, 2025
Westwood Management Corp. (Texas)
881.91K
1.79%
+20.63K
+2.39%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco Pharmaceuticals ETF
2.44%
State Street SPDR S&P Pharmaceuticals ETF
2.43%
Schwab Ariel Opportunities ETF
2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.05%
Congress SMid Growth ETF
1.94%
Invesco S&P SmallCap Health Care ETF
1.83%
iShares U.S. Pharmaceuticals ETF
1.1%
Brandes US Small-Mid Cap Value ETF
0.84%
Invesco S&P SmallCap Low Volatility ETF
0.71%
JPMorgan Active Small Cap Value ETF
0.68%
查看更多
Invesco Pharmaceuticals ETF
占比2.44%
State Street SPDR S&P Pharmaceuticals ETF
占比2.43%
Schwab Ariel Opportunities ETF
占比2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比2.05%
Congress SMid Growth ETF
占比1.94%
Invesco S&P SmallCap Health Care ETF
占比1.83%
iShares U.S. Pharmaceuticals ETF
占比1.1%
Brandes US Small-Mid Cap Value ETF
占比0.84%
Invesco S&P SmallCap Low Volatility ETF
占比0.71%
JPMorgan Active Small Cap Value ETF
占比0.68%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Prestige Consumer Healthcare Inc的前五大股东是谁？
Prestige Consumer Healthcare Inc 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：7.03M，占总股份比例：14.28%。
The Vanguard Group, Inc.持有股份：5.62M，占总股份比例：11.42%。
Ariel Investments, LLC持有股份：2.20M，占总股份比例：4.47%。
Dimensional Fund Advisors, L.P.持有股份：2.47M，占总股份比例：5.02%。
Kayne Anderson Rudnick Investment Management, LLC持有股份：1.75M，占总股份比例：3.55%。
BlackRock Institutional Trust Company, N.A.持有股份：7.03M，占总股份比例：14.28%。
The Vanguard Group, Inc.持有股份：5.62M，占总股份比例：11.42%。
Ariel Investments, LLC持有股份：2.20M，占总股份比例：4.47%。
Dimensional Fund Advisors, L.P.持有股份：2.47M，占总股份比例：5.02%。
Kayne Anderson Rudnick Investment Management, LLC持有股份：1.75M，占总股份比例：3.55%。
Prestige Consumer Healthcare Inc的前三大股东类型是什么？
Prestige Consumer Healthcare Inc 的前三大股东类型分别是：
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Ariel Investments, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Ariel Investments, LLC
有多少机构持有Prestige Consumer Healthcare Inc(PBH)的股份？
截至2025Q3，共有667家机构持有Prestige Consumer Healthcare Inc的股份，合计持有的股份价值约为52.11M，占公司总股份的108.37%。与2025Q2相比，机构持股有所增加，增幅为-0.78%。
哪个业务部门对Prestige Consumer Healthcare Inc的收入贡献最大？
在FY2025，--业务部门对Prestige Consumer Healthcare Inc的收入贡献最大，创收--，占总收入的--%。
